Form 4: Encompass Health Director Boosts Equity Holdings

Encompass Health Corp. Director Nancy M. Schlichting acquired 33 additional restricted stock units tied to a common stock dividend payment.

Summary

• Nancy M. Schlichting, a Director of Encompass Health Corp. (EHC), acquired 33 shares of common stock.
• The transaction occurred on October 15, 2025.
• These shares were awarded as Restricted Stock Units (RSUs) credited to her non-employee director's account.
• The RSUs were granted in connection with a common stock dividend payment.
• Encompass Health paid a dividend of $0.19 per share on October 15, 2025, with a closing price of $123.65.
• Following this transaction, Nancy M. Schlichting beneficially owns 21,219 shares.

Sentiment

Score: 6

Explanation: The filing reflects a routine, expected transaction related to director compensation and equity accumulation. It is slightly positive as it indicates continued alignment of director interests with shareholders, but it is not a significant market-moving event.

Positives

• Increased equity ownership by a director, aligning their interests with shareholders.
• The RSU award mechanism is tied to dividend payments, providing a consistent method for director compensation and equity accumulation.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding future company performance or strategic direction.

Management Comments

• Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments.
• The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date.

Industry Context

The practice of compensating non-employee directors with equity, often through restricted stock units tied to dividend payments, is a common corporate governance practice across various industries, including healthcare. This method aims to align director incentives with long-term shareholder value creation.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of non-employee director compensation is a standard practice observed in many publicly traded companies, including peers in the healthcare sector such as HCA Healthcare (HCA) and Universal Health Services (UHS).
• Linking RSU awards to dividend payments, effectively a dividend reinvestment for equity compensation, is also a common mechanism to ensure directors benefit from and are incentivized by the company's financial performance and shareholder returns.
• The specific number of units awarded is a function of the company's dividend policy and stock price, which varies by company, but the underlying mechanism is consistent with broader market practices for director equity compensation.

Stakeholder Impact

• Shareholders: Minor, routine dilution from the issuance of RSUs, but generally viewed positively as it aligns director incentives with shareholder interests.
• Directors: Increased equity stake in the company, enhancing their personal investment and commitment to the company's long-term success.

Next Steps

• No specific future actions or milestones are mentioned in this routine Form 4 filing.

Key Dates

Keywords

Encompass Health, EHC, Nancy M. Schlichting, Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Ownership, Dividend Reinvestment